Michael A. Arnold is Chair of the ISPE International Board of Directors and Investigational Product Business Process Owner for Pfizer's Global Clinical Supply Chain. In this capacity he is responsible for several Review Boards focused on Quality and business process improvements for Investigational Products. He has worked in the Pharmaceutical Industry for the past 36 years. Mr. Arnold is the current Chair of the ISPE New Content Advisory Group, a member and Past Chair of the ISPE Investigational Products Community of Practice, a member of the ISPE Regulatory Subcommittee, a member and Past Chair of the ISPE Community of Practice Council, Past-Chair of the ISPE Quality Metrics Governance Team, and a member of the Global Pharmaceutical Manufacturing Leadership Forum (GPMLF). He is a contributing author to ISPE’s Good Practice Guide on Interactive Response Technology and has been a speaker at several local and international educational events. In 2011 ISPE named him its Member of the Year. Mr. Arnold holds a BS in Pharmacy from the University of Rhode Island College of Pharmacy and is a licensed and registered pharmacist in the state of Connecticut. In 2012 he was elected “Pharmacist of the Year” by the Connecticut Society of Health Systems Pharmacists.